Clinical Analyzers can be used for a wide range of applications such as blood gas, chemistry, coagulation, electrolyte, hematology, urinalysis and immunoassay. A recent report from Persistence Market Research predicts that the clinical analyzer market will witness steady growth up to 2021. According to the report, North America currently dominates the global clinical analyzer market, followed by Europe. Several factors have been identified as driving this growth such as the rising prevalence of infectious and non-infectious diseases, increasing demand for laboratory automation in the clinical laboratories in these regions, and rise in the number of healthcare insurance holders, especially in the U.S.
Asia is expected to be the fastest growing market in the next five years. This is due to the expanding healthcare infrastructure, increasing government initiatives for better health care facilities, and the presence of a large patient population base in the region.
Some of the recent trends witnessed in this global market include increasing demand for high throughput clinical analyzers and modular automated analyzers and rising number of product innovations. The key factors driving the growth of the global clinical analyzer market according to the report are:
- Rising aging population
- Increasing number of reagent rental agreements
- Increase in lifestyle associated disorders
- Rising per capita income in developing countries
- Increasing health care awareness
However, the study found that factors such as high capital requirement and the stringent regulatory policies imposed by the various governments for medical devices are restraining the growth of the global clinical analyzer market. The high cost of clinical analyzers also impedes market growth.
The report notes that while the increasing number of consolidations in the market could restrain the entry of new players, maintaining accuracy and quality of clinical chemistry analyzers could pose a challenge for the growth of the market.
The leading manufacturers operating in this market are Abbott Laboratories, Randox Laboratories Ltd., Thermo Fisher Scientifc Inc., Siemens AG, Danaher Corporation, Mindray Medical International Limited, and ELITechGroup. Factors that could create opportunities for new players include technological advancements in automation systems, including hardware and software, availability of cost-effective analyzers and emerging markets such as India and China.